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Influenza  viruses  are  RNA  viruses  and  are  a  common 
cause of respiratory infection, with seasonal type A and B 
influenza  viruses  reaching  peak  prevalence  during  the 
winter months. As the 2009 H1N1 pandemic influenza 
and the sporadic human deaths from H5N1 highly patho­
genic avian influenza illustrate, the risk of novel patho­
genic  strains  emerging  from  animal  reservoirs  is  ever 
present. Understanding of the molecular bases of viral 
pathogenesis,  human  susceptibility  and  immune  res­
ponses is crucial for the development of new vaccines, 
targeted diagnostics and antiviral drugs.
Human exposure to influenza viruses can lead to a wide 
variety of pathological outcomes. Whereas some people 
succumb to symptomatic (Sx) infection, others apparently 
show few symptoms. Severe influenza A virus infections 
can result in pneumonia and immuno  pathology charac­
ter  ized by high oxidative stress, high levels of pro­inflam­
matory  chemokines  and  cytokines  (hypercytokinemia), 
and  acute  respiratory  distress  syndrome  [1,2].  The 
influenza virus is cleared mainly through the generation 
of  cytotoxic  T  lymphocytes  (CTLs)  and  neutralizing 
anti  bodies,  and  future  infections  are  prevented  by 
adaptive immune responses that are capable of targeting 
antigeni  cally  similar  strains.  Neutralizing  antibodies, 
which  are  generated  during  natural  infection  and  by 
currently  approved  influenza  vaccines,  primarily  target 
surface glycoproteins, hemagglutinin and neuraminidase 
and are strongly associated with protection. However, the 
first response to influenza virus infection is mediated by 
the innate immune system.
The early host innate immune response is triggered by 
recognition  of  the  viral  RNA  by  pathogen­recognition 
receptors  (PRRs;  such  as  Rig­I,  TLR3/7  and  NLRP3). 
Responding  primarily  in  antigen­presenting  dendritic 
cells resident in the respiratory tract, Rig­I and TLR3/7 
induce type I IFN (IFNβ and IFNα). Induction of IFNβ/α 
leads  to  induction  of  antiviral,  interferon­stimulated 
genes and cytokine/chemokine signals that recruit innate 
immune effector cells and adaptive immune mechanisms 
[3,4].  In  influenza  virus  infection,  oxidative  stress  also 
activates the NLRP3 inflammasome, which is an oligo­
meric  complex  of  NLRP3  that  senses  cellular  ‘danger 
signals’  and  possibly  viral  RNA  [5].  NLRP3  contains  a 
caspase activation and recruitment domain that activates 
caspase 1, which in turn leads to the proteolytic proces­
sing and release of pro­inflammatory cytokines IL1β and 
IL18 [6]. The NLRP3 inflammasome facilitates influenza 
virus  clearance  by  mediating  recruitment  of  innate 
immune cells to the lung, and is required for lung repair 
and survival in mice [5,7].
Microarray analyses of host responses to experimental 
influenza virus infection in animal models have yielded 
an  unprecedented  look  into  the  complex  molecular 
dynamics  regulating  viral  pathogenesis,  innate  and 
adaptive immune responses, and inflammation. However, 
the  transcriptional  dynamics  of  host  responses  to 
influenza virus infections in humans have been less well 
studied.  To  address  this  question,  Huang  et  al.  [8] 
undertook a novel set of clinical genomics experiments, 
reported in PLoS Genetics, which we discuss below.
Dynamic response to infection
Huang et al. [8] recruited human volunteers and infected 
them  with  the  human  seasonal  influenza  strain  A/
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peripheral  blood  cell  transcriptional  responses  using 
micro  arrays before and during the course of infection (0 
to 108 h post­infection). Importantly, all volunteers were 
immunologically naïve for H3N2­specific antibodies and 
had not been vaccinated for at least 3 years.
Significant  differences  in  transcriptional  profiles 
between Sx and subclinical/asymptomatic (Asx) infection 
were  found.  Applying  rigorous  statistical  methods, 
includ  ing  unsupervised  Bayesian  analysis  and  clinically 
informed pathway enrichment, Huang et al. mapped the 
temporal  dynamics  of  clusters  of  genes  and  corres­
ponding cellular pathways. In Sx subjects, influenza virus 
significantly induced antiviral, inflammatory and immune 
response gene clusters over the course of an infection [8]. 
They also detected distinct profiles in Asx patients.
The inflammasome is a key to host response
There is substantial evidence that influenza virus infec­
tion  causes  the  induction  of  specific  innate  immune, 
inflammatory and oxidative stress pathways in lung tissue 
and peripheral blood cells in humans and animal models 
[1,9,10].  Induction  of  the  NLRP3  inflammasome  path­
ways in particular correlate with the onset of symptoms, 
and are highly upregulated in lung tissue in lethal 1918 
influenza  virus  infection  in  macaques  [1].  Similarly, 
Huang  et  al.  found  that  symptomatic  influenza  virus 
infection  induces  a  gene  signature  in  peripheral  blood 
cells that is enriched in pathogen recognition receptor, 
type I IFN, inflammasome and pro­inflammatory cyto­
kine response genes [8]. While induction of these path­
ways was not unexpected, the novelty of this study lies in 
comparison with Asx subjects.
In contrast to Sx infection, suppression of the inflam­
masome  by  limiting  oxidative  stress  may  dictate  a 
success  ful  early  response  to  infection,  leading  to  Asx 
exposure. Huang et al. present substantial evidence that 
the Asx group showed ‘subclinical’ influenza virus infec­
tion (50% shed virus, 25% showed seroconversion, and all 
showed similar expression changes in 3,000 genes) [8]. 
This  suggests  that  the  Asx  phenotype  was  evidence  of 
host limitation of influenza virus infection rather than a 
failed  inoculation.  Asx  subjects  showed  differential 
upregulation of antioxidant genes (SOD1 and STK25) and 
Figure 1. Model of differential outcomes of influenza virus infection in humans. In symptomatic cases, early virus replication is not controlled, 
and innate immune sensors (pathogen-recognition receptors) and inflammasome activation lead to inflammatory responses. In late stages 
of infection, lungs exhibit immunopathology, and cytokines signal to recruit innate effector cells and engage adaptive immune responses. In 
asymptomatic or subclinical cases, early virus infection is controlled, antioxidant responses are induced, and inflammasome genes are repressed, 
leading to an absence of inflammation and disease. CTL, cytotoxic T lymphocyte; hpi, hours post-infection; IFN, interferon; NK, natural killer; PRR, 
pathogen-recognition receptor.
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suppression  of  NLRP3.  Taking  into  account  that  the 
peripheral  blood  cells  from  which  the  gene  expression 
profile  were  taken  are  at  a  distance  from  the  site  of 
influenza  virus  replication  (the  upper  respiratory  tract 
and lungs), the nature of the Asx phenotype is suggestive 
of  an  ‘immediate­early’  decision  point  upon  influenza 
virus infection of the respiratory tract (Figure 1). Control 
of  oxidative  stress  and  suppression  of  the  NLRP3 
inflammasome  may  directly  limit  viral  replication,  or 
correlate  with  induction  of  a  potent  antiviral  response 
that targets virus­infected cells before enough viral RNA 
is produced and recognized by PRR to lead to widespread 
induction of innate immune pathways such as IFNβ/α.
However,  there  is  a  confounding  possibility.  Asx 
subjects may have been able to mount a CTL­mediated 
immune response upon infection; it is possible that Asx 
subjects might only have been immunologically naïve in 
terms of H3N2 antibody titers. Protein synthesis machi­
nery was strongly induced in peripheral blood cell RNA 
of Asx subjects, and there were significant increases in 
peripheral leukocyte counts [8]. Despite this, influenza­
specific CTL activity was not measured, so it is unknown 
whether  the  Asx  phenotype  was  dependent  on  the 
presence  of  circulating,  respiratory­tract­resident  or 
lung­resident T­cell memory targeting conserved cross­
reactive influenza virus epitopes. Indeed, CTLs raised (in 
mice) against H3N2 virus are capable of recognizing epi­
topes in internal proteins (nucleoprotein and polymerase) 
of a divergent avian H5N1 virus, and contributing to a 
cross­protective, heterosubtypic response [11].
Genomics leads the way
Besides investigating the nature of the immediate­early 
repression of virus replication observed in Asx subjects, 
future genomics studies in human and animal models of 
influenza virus infections can apply similarly innovative 
approaches  to  genomics  and  clinical/physiological  data 
analysis  [8]  to  yield  deeper  insight  into  differences  in 
gene expression signatures in distinct leukocyte subsets 
in peripheral blood. How do gene expression patterns in 
peripheral blood cell subsets compare with those in cell 
populations (epithelial, endothelial, lymphocytic, dendritic 
cells and macrophages) in the respiratory tract [9]? From 
a practical view, it is likely that biomarkers that differ­
entiate early from late symptomatic influenza virus infec­
tion could be obtained by analyzing peripheral blood [8]. 
Advancing genomics­based diagnostic methods may not 
only contribute to understanding the molecular events 
leading to symptomatic influenza in human patients, but 
may also aid the development of point­of­care diagnostics 
for  patients  and  their  close  contacts  for  the  early 
initiation of antiviral treatment.
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